Dental Market Radar

Fact · Sleep

Adult OSA prevalence (%): Australia, 2019

In 2019, the prevalence of obstructive sleep apnea among adults in Australia was 4.8%, according to The Lancet Respiratory Medicine Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019. Basis: estimate.

Comparability C Confidence low

Cite this

The Lancet Respiratory Medicine (PMC author manuscript). (2026). Adult OSA prevalence (%): Australia, as of 2019-08-31 [Data set]. Compiled by Dental Market Radar. https://dentalmarketradar.com/data/au/osa-prevalence-adult-pct/2019/

Permanent URL: https://dentalmarketradar.com/data/au/osa-prevalence-adult-pct/2019/. Licensed under CC BY 4.0.

Record

Value
4.8%
Unit
percent
As of
Accessed
Revision
1
Confidence
low
Method
estimate
Basis
estimate
Scope
estimate
Comparability
Comparability C C: different basis; use with caution when comparing
Status
Latest record for this market and metric

Source quote

Australia 12 110 362 2 966 536 (24·5%) 581 348 (4·8%)

Locator: Appendix table of country estimates, Australia row (as reproduced on PMC)

Local definition

Adults aged 30-69 with obstructive sleep apnoea, AHI >=15 events/hour (modelled)

Source

The Lancet Respiratory Medicine (PMC author manuscript): Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019. Registry entry: au-benjafield-2019.

Notes

Modelled estimate: population aged 30-69 12,110,362; AHI>=5 2,966,536 (24.5%); AHI>=15 581,348 (4.8%). Australian input study (n=380, 2008, ages 40-65) listed in the paper. Not a national survey. Same method as JP record for cross-country comparability.

Metric definition

Adult obstructive sleep apnea prevalence All markets for this metric.

History

Current records for Adult OSA prevalence (%), Australia, newest first
YearValueBasisAs ofComparabilitySourceSeries break
20194.8%estimateComparability CBenjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019

Please also cite the original source above.

Same metric in other markets

Japan Singapore Thailand Vietnam New Zealand